The particular interactions of the traditional cardiovascular risk factors with different circulating specific leukocyte subtype counts in blood: An observational study;Geleneksel kardiyovasküler risk faktörlerinin dolaşımdaki farklı özgül lökosit alt tip sayımları ile belirli etkileşimleri: Gözlemsel bir çalışma

Anadolu Kardiyoloji Dergisi

Volumn 11, Issue 7, 2011, Pages 573-581

  Kocaman, Sinan Altan ^a   Şahinarslan, Asife ^a   Kunak, Tolga ^a   Balcioǧlu, Serhat ^a   Çetin, Mustafa ^b   Cemri, Mustafa ^a   Timurkaynak, Timur ^a   Boyaci, Bülent ^a   Çengel, Atiye ^a  

^a GAZI UNIVERSITY   (Turkey)

^b Rize Education and Research Hospital   (Turkey)

Author keywords

Cardiovascular risk factors; Coronary artery disease; Inflammatory cells; Lymphocyte; Monocyte; Neutrophil; Neutrophil to lymphocyte ratio; Regression analysis

Indexed keywords

CREATININE; GLUCOSE; HIGH DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN; TRIACYLGLYCEROL; URIC ACID;

ADULT; AGE; ANGIOCARDIOGRAPHY; ARTICLE; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; CORONARY ARTERY DISEASE; CREATININE BLOOD LEVEL; CROSS-SECTIONAL STUDY; FAMILY HISTORY; FEMALE; GLUCOSE BLOOD LEVEL; HEMATOLOGICAL PARAMETERS; HUMAN; HYPERTENSION; LEUKOCYTE COUNT; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; MONOCYTE COUNT; NEUTROPHIL COUNT; NEUTROPHIL LYMPHOCYTE RATIO; OBSERVATIONAL STUDY; SEX DIFFERENCE; SMOKING; URIC ACID BLOOD LEVEL;

EID: 80054685172     PISSN: 13028723     EISSN: None     Source Type: Journal    
DOI: 10.5152/akd.2011.158     Document Type: Article

References (40)

1. Hansson GK. Inflammation, atherosclerosis, and coronary artery disease. N Engl J Med 2005; 352: 1685-95. [CrossRef]
2. Gerrity RG. The role of the monocyte in atherogenesis: I. Transition of blood-borne monocytes into foam cells in fatty lesions. Am J Pathol 1981; 103: 181-90.
3. Gerrity RG. The role of the monocyte in atherogenesis: II. Migration of foam cells from atherosclerotic lesions. Am J Pathol 1981; 103: 191-200.
4. Moreno PR, Falk E, Palacios IF, Newell JB, Fuster V, Fallon JT. Macrophage infiltration in acute coronary syndromes. Implications for plaque rupture. Circulation 1994; 90: 775-8. [CrossRef]
5. Ross R, Glomset J, Harker L. Response to injury and atherogenesis. Am J Pathol 1977; 86: 675-84.
6. Gulati R, Jevremovic D, Peterson TE, Witt TA, Kleppe LS, Mueske CS, et al. Autologous culture-modified mononuclear cells confer vascular protection after arterial injury. Circulation 2003; 108: 1520-6. [CrossRef]
7. He T, Smith LA, Harrington S, Nath KA, Caplice NM, Katusic ZS. Transplantation of circulating endothelial progenitor cells restores endothelial function of denuded rabbit carotid arteries. Stroke 2004; 35: 2378-84. [CrossRef]
8. Rauscher FM, Goldschmidt-Clermont PJ, Davis BH, Wang T, Gregg D, Ramaswami P, et al. Aging, progenitor cell exhaustion, and atherosclerosis. Circulation 2003; 108: 457-63. [CrossRef]
9. Wassmann S, Werner N, Czech T, Nickenig G. Improvement of endothelial function by systemic transfusion of vascular progenitor cells. Circ Res 2006; 99: e74-83. [CrossRef]
10. Asahara T, Murohara T, Sullivan A, Silver M, van der Zee R, Li T, et al. Isolation of putative progenitor endothelial cells for angiogenesis. Science 1997; 275: 964-7. [CrossRef]
11. Vasa M, Fichtlscherer S, Aicher A, Adler K, Urbich C, Martin H, et al. Number and migratory activity of circulating endothelial progenitor cells inversely correlate with risk factors for coronary artery disease. Circ Res 2001; 89: E1-7. [CrossRef]
12. Hill JM, Zalos G, Halcox JP, Schenke WH, Waclawiw MA, Quyyumi AA, et al. Circulating endothelial progenitor cells, vascular function, and cardiovascular risk. N Engl J Med 2003; 348: 593-600. [CrossRef]
13. Turan RG, Brehm M, Koestering M, Tobias Z, Bartsch T, Steiner S, et al. Factors influencing spontaneous mobilization of CD34+ and CD133+ progenitor cells after myocardial infarction. Eur J Clin Invest 2007; 37: 842-51. [CrossRef]
14. Horne BD, Anderson JL, John JM, Weaver A, Bair TL, Jensen KR, et al. Intermountain Heart Collaborative Study Group. Which white blood cell subtypes predict increased cardiovascular risk? J Am Coll Cardiol 2005; 45:1638-43. [CrossRef]
15. Núñez J, Núñez E, Bodí V, Sanchis J, Miñana G, Mainar L, et al. Usefulness of the neutrophil to lymphocyte ratio in predicting longterm mortality in ST segment elevation myocardial infarction. Am J Cardiol 2008; 101: 747-52. [CrossRef]
16. Papa A, Emdin M, Passino C, Michelassi C, Battaglia D, Cocci F. Predictive value of elevated neutrophil-lymphocyte ratio on cardiac mortality in patients with stable coronary artery disease. Clin Chim Acta 2008; 395: 27-31. [CrossRef]
17. Sabatine MS, Morrow DA, Cannon CP, Murphy SA, Demopoulos LA, DiBattiste PM, et al. Relationship between baseline white blood cell count and degree of coronary artery disease and mortality in patients with acute coronary syndromes: a TACTICS-TIMI 18 (Treat Angina with Aggrastat and determine Cost of Therapy with an Invasive or Conservative Strategy-Thrombolysis in Myocardial Infarction 18 trial) substudy. J Am Coll Cardiol 2002; 40: 1761-8. [CrossRef]
18. Gimbrone MA Jr, Topper JN, Nagel T, Anderson KR, Garcia-Cardeña G. Endothelial dysfunction, hemodynamic forces, and atherogenesis. Ann N Y Acad Sci 2000; 902: 230-9. [CrossRef]
19. Ross R. Atherosclerosis-an inflammatory disease. N Engl J Med 1999; 340: 115-26. [CrossRef]
20. Libby P. Vascular biology of atherosclerosis: overview and state of the art. Am J Cardiol 2003; 91: 3A-6A. [CrossRef]
21. Libby P. Molecular basis of the acute coronary syndromes. Circulation 1995; 91: 2844-50.
22. Falk E, Shah P, Fuster V. Coronary plaque disruption. Circulation 1995; 92: 657-71. [CrossRef]
23. Tomiyama H, Koji Y, Yambe M, Motobe K, Shiina K, Gulnisa Z, et al. Elevated C-reactive protein augments increased arterial stiffness in subjects with the metabolic syndrome. Hypertension 2005; 45: 997-1003. [CrossRef]
24. Hoffman M, Blum A, Baruch R, Kaplan E, Benjamin M. Leukocytes and coronary heart disease. Atherosclerosis 2004; 172: 1-6. [CrossRef]
25. Chapman CM, Beilby JP, McQuillan BM, Thompson PL, Hung J. Monocyte count, but not C-reactive protein or interleukin-6, is an independent risk marker for subclinical carotid atherosclerosis. Stroke 2004; 35: 1619-24. [CrossRef]
26. Johnsen SH, Fosse E, Joakimsen O, Mathiesen EB, Stensland-Bugge E, Njølstad I, et al. Monocyte count is a predictor of novel plaque formation: a 7-year follow-up study of 2610 persons without carotid plaque at baseline the Tromsø Study. Stroke 2005; 36: 715-9. [CrossRef]
27. Huang ZS, Wang CH, Yip PK, Yang CY, Lee TK. In hypercholesterolemia, lower peripheral monocyte count is unique among the major predictors of atherosclerosis. Arterioscler Thromb Vasc Biol 1996; 16: 256-61. [CrossRef]
28. Nasir K, Guallar E, Navas-Acien A, Criqui MH, Lima JA. Relationship of monocyte count and peripheral arterial disease: Results from the National Health and Nutrition Examination Survey 1999-2002. Arterioscler Thromb Vasc Biol 2005; 25: 1966-71. [CrossRef]
29. Horne BD, Anderson JL, John JM, Weaver A, Bair TL, Jensen KR, et al. Which white blood cell subtypes predict increased cardiovascular risk? J Am Coll Cardiol 2005; 45: 1638-43. [CrossRef]
30. Olivares R, Ducimetière P, Claude JR. Monocyte count: a risk factor for coronary heart disease? Am J Epidemiol 1993; 137: 49-53.
31. Horne BD, Anderson JL, John JM, Weaver A, Bair TL, Jensen KR, et al. Intermountain Heart Collaborative Study Group. Which white blood cell subtypes predict increased cardiovascular risk? J Am Coll Cardiol 2005; 45: 1638-43. [CrossRef]
32. Ganguli D, Das N, Saha I, Sanapala KR, Chaudhuri D, Ghosh S, et al. Association between inflammatory markers and cardiovascular risk factors in women from Kolkata, W. B, India. Arq Bras Cardiol 2011; 96: 38-46. [CrossRef]
33. Shim WS, Kim HJ, Kang ES, Ahn CW, Lim SK, Lee HC, et al. The association of total and differential white blood cell count with metabolic syndrome in type 2 diabetic patients. Diabetes Res Clin Pract 2006; 73: 284-91. [CrossRef]
34. Ruggiero C, Cherubini A, Ble A, Bos AJ, Maggio M, Dixit VD, et al. Uric acid and inflammatory markers. Eur Heart J 2006; 27: 1174-81.
35. Drechsler M, Megens RT, van Zandvoort M, Weber C, Soehnlein O. Hyperlipidemia-triggered neutrophilia promotes early atherosclerosis. Circulation 2010; 122: 1837-45. [CrossRef]
36. Tian N, Penman AD, Mawson AR, Manning RD Jr, Flessner MF. Association between circulating specific leukocyte types and blood pressure: the atherosclerosis risk in communities (ARIC) study. J Am Soc Hypertens 2010; 4: 272-83. [CrossRef]
37. Kawada T, Morihashi M, Ueda H, Sirato T. Neutrophil cell count is related to hypertension in workers: a cross-sectional study. Vasc Dis Prev 2007: 4; 225-8. [CrossRef]
38. Yen ML, Yang CY, Yen BL, Ho YL, Cheng WC, Bai CH. Increased high sensitivity C-reactive protein and neutrophil count are related to increased standard cardiovascular risk factors in healthy Chinese men. Int J Cardiol 2006; 110:191-8. [CrossRef]
39. Lavi S, Prasad A, Yang EH, Mathew V, Simari RD, Rihal CS, et al. Smoking is associated with epicardial coronary endothelial dysfunction and elevated white blood cell count in patients with chest pain and early coronary artery disease. Circulation 2007; 115: 2621-7. [CrossRef]
40. Tani S, Nagao K, Anazawa T, Kawamata H, Furuya S, Takahashi H, et al. Association of leukocyte subtype counts with coronary atherosclerotic regression following pravastatin treatment. Am J Cardiol 2009; 104: 464-9. [CrossRef]